Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice

被引:52
作者
Mallet, VO
Mitchell, C
Guidotti, JE
Jaffray, P
Fabre, M
Spencer, D
Arnoult, D
Kahn, A
Gilgenkrantz, H
机构
[1] Cochin Inst, Dept Genet Dev & Mol Pathol, F-75014 Paris, France
[2] Cochin Inst, Biochem Lab, F-75014 Paris, France
[3] Hop Bicetre, Pathol Lab, F-94275 Le Kremlin Bicetre, France
[4] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[5] Hop Bichat Claude Bernard, INSERM, U9922, EMI, F-75877 Paris 18, France
关键词
D O I
10.1038/nbt762
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Studying the effects of the loss of a specific cell type is a powerful approach in biology. Here we present a method based on the controlled activation of the apoptotic machinery. We expressed a modified caspase-3-containing chemical inducer of dimerization (CID)-binding sites in the livers of transgenic mice. In the absence of CID, no liver injury was detectable, underlining the absence of leakage in our system. In contrast, injection of the CID produced activation of the chimeric caspase-3, which led to a dose-dependent pure hepatocyte ablation with subsequent regeneration. This method is effective in both growing and nongrowing cells, and is therefore applicable to a wide range of cells and tissues. Moreover, because apoptosis has been described in numerous pathological circumstances, this system is useful for generating mouse models of human disorders as well as for studying the recovery or regeneration of tissues after cell loss.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 39 条
[1]   DWARF MICE PRODUCED BY GENETIC ABLATION OF GROWTH HORMONE-EXPRESSING CELLS [J].
BEHRINGER, RR ;
MATHEWS, LS ;
PALMITER, RD ;
BRINSTER, RL .
GENES & DEVELOPMENT, 1988, 2 (04) :453-461
[2]  
Braun KM, 2000, NAT MED, V6, P320
[3]   ACUTE LIVER-FAILURE [J].
CARACENI, P ;
VANTHIEL, DH .
LANCET, 1995, 345 (8943) :163-169
[4]   Conversion of Bcl-2 to a Bax-like death effector by caspases [J].
Cheng, EHY ;
Kirsch, DG ;
Clem, RJ ;
Ravi, R ;
Kastan, MB ;
Bedi, A ;
Ueno, K ;
Hardwick, JM .
SCIENCE, 1997, 278 (5345) :1966-1968
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]   Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity [J].
Clackson, T ;
Yang, W ;
Rozamus, LW ;
Hatada, M ;
Amara, JF ;
Rollins, CT ;
Stevenson, LF ;
Magari, SR ;
Wood, SA ;
Courage, NL ;
Lu, XD ;
Cerasoli, F ;
Gilman, M ;
Holt, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10437-10442
[7]  
COLLIER RJ, 1990, ADP RIBOSYLATING TOX, P3, DOI DOI 10.1126/SCIENCE.250.4982.841-A
[8]   INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].
CULVER, KW ;
RAM, Z ;
WALLBRIDGE, S ;
ISHII, H ;
OLDFIELD, EH ;
BLAESE, RM .
SCIENCE, 1992, 256 (5063) :1550-1552
[9]   Improved artificial death switches based on caspases and FADD [J].
Fan, LF ;
Freeman, KW ;
Khan, T ;
Pham, E ;
Spencer, DM .
HUMAN GENE THERAPY, 1999, 10 (14) :2273-2285
[10]   Liver regeneration [J].
Fausto, N .
JOURNAL OF HEPATOLOGY, 2000, 32 :19-31